These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11732225)

  • 21. Menstrual patterns under hormonal contraception in adolescent girls and young women.
    Heinz M
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():146-9. PubMed ID: 16641849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.
    Hosking D; Chilvers CE; Christiansen C; Ravn P; Wasnich R; Ross P; McClung M; Balske A; Thompson D; Daley M; Yates AJ
    N Engl J Med; 1998 Feb; 338(8):485-92. PubMed ID: 9443925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.
    Lindsay R; Nieves J; Formica C; Henneman E; Woelfert L; Shen V; Dempster D; Cosman F
    Lancet; 1997 Aug; 350(9077):550-5. PubMed ID: 9284777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Results from the Registry of Complications in Users of Hormonal Contraception in 1998].
    Cibula D; Zivný J; Horejsí J; Hill M
    Ceska Gynekol; 2000 Mar; 65(2):75-9. PubMed ID: 10953474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Predictors of combined hormone contraception choice between Czech and Slovak women].
    Fait T
    Ceska Gynekol; 2011 Jun; 76(3):190-3. PubMed ID: 21838148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term effects of an oral contraceptive containing oestradiol valerate and dienogest on bone metabolism and bone mineral density: an observational, preliminary study.
    Di Carlo C; Gargano V; Sparice S; Tommaselli GA; Bifulco G; Schettino D; Nappi C
    Eur J Contracept Reprod Health Care; 2013 Oct; 18(5):388-93. PubMed ID: 23859010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal evaluation of perimenopausal femoral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism.
    Gambacciani M; Ciaponi M; Cappagli B; Benussi C; Genazzani AR
    Osteoporos Int; 2000; 11(6):544-8. PubMed ID: 10982172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women.
    Gai L; Jia Y; Zhang M; Gai P; Wang S; Shi H; Yu X; Liu Y
    Contraception; 2012 Oct; 86(4):332-6. PubMed ID: 22364818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Importance of the consultation for combined hormonal contraception's choice--results of CHOICE project in Czech and Slovak Republic].
    Fait T; Apetauer I
    Ceska Gynekol; 2011 Apr; 76(2):140-4. PubMed ID: 21649999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flaxseed combined with low-dose estrogen therapy preserves bone tissue in ovariectomized rats.
    Sacco SM; Jiang JM; Reza-López S; Ma DW; Thompson LU; Ward WE
    Menopause; 2009; 16(3):545-54. PubMed ID: 19182694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Awareness of the influence of progestin contraceptives on bone mineral content].
    Jamin C
    Presse Med; 2002 Nov; 31(37 Pt 1):1731-2. PubMed ID: 12489314
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of continuous combined hormone replacement therapy and clodronate on bone mineral density in osteoporotic postmenopausal women: a 5-year follow-up.
    Tuppurainen M; Härmä K; Komulainen M; Kiviniemi V; Kröger H; Honkanen R; Alhava E; Jurvelin J; Saarikoski S
    Maturitas; 2010 Aug; 66(4):423-30. PubMed ID: 20547017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Continuous use--the important trend of combined hormonal contraception].
    Cibula D
    Ceska Gynekol; 2006 Jan; 71(1):66-9. PubMed ID: 16465919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.
    Liberman UA; Weiss SR; Bröll J; Minne HW; Quan H; Bell NH; Rodriguez-Portales J; Downs RW; Dequeker J; Favus M
    N Engl J Med; 1995 Nov; 333(22):1437-43. PubMed ID: 7477143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.
    McClung MR; Wasnich RD; Recker R; Cauley JA; Chesnut CH; Ensrud KE; Burdeska A; Mills T;
    J Bone Miner Res; 2004 Jan; 19(1):11-8. PubMed ID: 14753731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drugs for prevention and treatment of postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2000 Oct; 42(1090):97-100. PubMed ID: 11035622
    [No Abstract]   [Full Text] [Related]  

  • 38. [What can we expect of raloxifene in the treatment of postmenopausal osteoporosis--views of a gynecologist].
    Chmel R; Rob L; Strnad P
    Ceska Gynekol; 2002 Jul; 67(4):187-91. PubMed ID: 12373918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of hormonal contraceptives on cardiovascular function].
    Manuilova IA; Dubnitskaia LV; Trutko NS
    Akush Ginekol (Mosk); 1983 Nov; (11):5-8. PubMed ID: 6364872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal evaluation of perimenopausal vertebral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism.
    Gambacciani M; Spinetti A; Taponeco F; Cappagli B; Piaggesi L; Fioretti P
    Obstet Gynecol; 1994 Mar; 83(3):392-6. PubMed ID: 8127531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.